2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Tmz: new trials by email Literature Review of Tmz trials Research Report on Tmz
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial in Low Grade Glioma Patients: Wait or Treat Temozolomide, Radiotherapy, Surgery - Low-grade Glioma, Temozolomide | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 19 | 2020-03-16 | 2022-02-01 |
| Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma trabedersen, temozolomide, Drug delivery system for administration of AP 12009 - Anaplastic Astrocytoma, Glioblastoma | Phase 3 | Terminated | Isarna Therapeutics GmbH | 27 | 2008-12-01 | 2014-11-14 |
Astrocytoma (1) · Brain Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Neoplasms (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Isarna Therapeutics GmbH (1)
Austria (2) · France (2) · Spain (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Denmark (1) · Germany (1) · Hungary (1) · India (1) · Italy (1) · Mexico (1)